Divi's Laboratories planning for capacity addition at manufacturing facility

25 Apr 2024 Evaluate

Divi's Laboratories is in the process of entering into a long-term supply agreement with a customer and is planning for capacity addition at its manufacturing facility with an estimated investment between Rs 650 crore to Rs 700 crore, to be funded from internal accruals. The proposed facility is expected to be operational around January 2027. Due to the confidentiality agreement signed with the customer, the Company is not permitted to disclose any further quantitative details.

Divi's Laboratories is one of the leading pharmaceutical companies in the world.

Divis Lab Share Price

6024.50 -191.05 (-3.07%)
25-Apr-2025 12:45 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1780.65
Dr. Reddys Lab 1166.60
Cipla 1522.85
Lupin 2038.10
Zydus Lifesciences 862.90
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...